Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
Holders of 5% or more of EVO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evotec SE, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Excalibur LuxCo SARL | 13D/A | 9.99%17.7M shares | – | Oct 29, 20251 filing | Oct 29, 2025 | SEC |
| MAK Capital Fund LP | 13D | 7.00%12.5M shares | +1.70 ppfrom 5.30% | Jan 16, 20262 filings | Mar 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Evotec SE, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 20268:29 PM ET | MAK Capital Fund LPand 2 others | 13D | 7.00%12.5M shares | +1.70 ppfrom 5.30% | Mar 30, 2026 | SEC |
| Feb 17, 20266:54 PM ET | Novo Holdings A/S | 13G/A | 0.00%0 shares | −5.30 ppfrom 5.30%Below 5% | Dec 31, 2025 | SEC |
| Jan 16, 20264:06 PM ET | MAK Capital Fund LPand 2 others | 13G | 5.30%9.39M shares | New | Jan 9, 2026 | SEC |
| Nov 14, 20256:30 PM ET | Novo Holdings A/S | 13G/A | 5.30%9.41M shares | – | Sep 30, 2025 | SEC |
| Oct 29, 20255:24 PM ET | Excalibur LuxCo SARLand 4 others | 13D/A | 9.99%17.7M shares | – | Oct 27, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Evotec SE shares.
No Form 144 notices for Evotec SE are on file.